LeMaitre Vascular Files 8-K on Director Changes
Ticker: LMAT · Form: 8-K · Filed: Aug 26, 2024 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-of-directors
Related Tickers: LMAV
TL;DR
LMAV board shakeup and comp changes filed. Watch for new exec pay details.
AI Summary
On August 26, 2024, LeMaitre Vascular, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of new directors and potential adjustments to executive compensation arrangements, though specific details on dollar amounts and new director names are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial priorities that may impact shareholder value.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate underlying strategic shifts or governance issues that may affect the company's future performance.
Key Players & Entities
- LeMaitre Vascular, Inc. (company) — Registrant
- August 26, 2024 (date) — Date of report
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but the specific names of newly elected directors are not detailed in this excerpt.
Were there any changes to executive officer positions?
The filing mentions "Appointment of Certain Officers," suggesting potential changes, but specific details are not provided in this excerpt.
What is the primary reason for this 8-K filing?
The filing is primarily to report on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported was on August 26, 2024.
What is LeMaitre Vascular's principal executive office address?
LeMaitre Vascular's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803.
Filing Stats: 689 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-08-26 16:12:49
Key Financial Figures
- $0.01 — nge on which registered Common stock , $0.01 par value per share LMAT The Nasdaq
Filing Documents
- lmat20240826_8k.htm (8-K) — 26KB
- 0001437749-24-027754.txt ( ) — 155KB
- lmat-20240826.xsd (EX-101.SCH) — 3KB
- lmat-20240826_def.xml (EX-101.DEF) — 11KB
- lmat-20240826_lab.xml (EX-101.LAB) — 15KB
- lmat-20240826_pre.xml (EX-101.PRE) — 11KB
- lmat20240826_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LEMAITRE VASCULAR, INC. Dated: August 26, 2024 By: /s/ George W. LeMaitre Name: George W. LeMaitre Title: Chief Executive Officer